Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Company details
The University of Edinburgh
The University of Edinburgh has an international reputation for world-class research in medicine and biotechnology.
The company in detail
Profile
The University of Edinburgh is one of the UK's largest and most successful research universities, with an international reputation for world-class research in medicine and biotechnology.
To ensure the effective commercialisation of its research, the University has created an environment that facilitates, encourages and supports this activity. This is managed by the University's technology transfer office, Edinburgh Research and Innovation (ERI), through the support and promotion of: Collaborative R&D; Technology Licensing; Consultancy Services; Company Formation & Incubation; and Science Parks.
Partnering strategy/interests
As a leading clinical research centre, the University is continually engaged in research collaborations with clinical centres, academic groups, biotechnology companies and pharmaceutical majors around the world, and is looking to increase the breadth and depth of these research partnerships within the areas of medicine and biotechnology, including: Bioinformatics; Cardiovascular Biology; Cell Biology; Genomics; Imaging; Infectious Diseases; Inflammatory Disease; Neuroscience; Oncology; Plant Science; Proteomics; Reproductive Biology and Health; Regenerative Medicine; Stem Cell Research; and Veterinary Medicine.
Out-licensing
Colloid scientists at the University of Edinburgh have invented a new generic route to gel formulation, involving particles suspended in fluid-bicontinuous mixture of two solvents. More
Researchers at the University of Edinburgh have developed OSCAR, a protein expression system with the potential to form a platform technology which will simplify the method of protein production in cultured mammalian cells. More
The University of Edinburgh has developed new methods for cleaning surgical instruments, which completely remove protein contamination, including prions - the infectious agents that cause Creutzfeldt-Jakob Disease (CJD) in humans. More
Researchers at the University of Edinburgh have identified two protein domains (MBD and CxxC) proven to isolate methylated and non-methylated CpG islands (CGIs), respectively. More
Researchers at the University of Edinburgh, led by Professor Peter Sadler, have developed a novel series of platinum prodrugs, which can be activated by light (photoactivated). More
The University of Edinburgh has discovered a binding site for zinc in human albumin. More
New solid phase synthesis technologies that employ polymer-supported reagents to reliably produce high yield, standard and complex nucleic acids More
The University of Edinburgh has developed a new method of screening for polymorphs and solvates of drug compounds that has potential to revolutionise the way polymorph screening is conducted. More
Researchers from the University of Edinburgh have generated a MBD3-deficient pluripotent embryonic stem cell line. More
Scientists at the University of Edinburgh have collaborated with transplantation surgeons to explore the possible benefits of novel additives to organ preservation solution. More
The University of Edinburgh has identified a hitherto unrecognised potential of IKr-specific Class III anti-arrhythmics for the treatment of inflammatory disorders in a number of disease states/models. More
Scientists at the University of Edinburgh have identified a novel therapeutic strategy for the treatment of inflammatory disorders. More
The University of Edinburgh has perfected a genetic engineering strategy in mouse embryonic stem cells to replace large regions of mouse chromosomal sequences (>100kb) with the corresponding human syntenic region. More
The University of Edinburgh, in collaboration with the SNBTS, Roslin Institute Neuropathogenesis Unit, and the University of Strathclyde, has developed an antibody that can distinguish abnormal PrP (PrPSc) from the normal cellular form (PrPC) More
Researchers at the University of Edinburgh have developed screening techniques that are able to identify if a patient has been exposed to a multiple organ failure initiating event, or is likely to develop multiple organ failure. More
Using a groundbreaking technique developed in astronomy, researchers at the University of Edinburgh are able to register complete 3D image volumes to sub-pixel accuracy in real-time More
A monoclonal antibody to the streptavidin binding epitope tag More
Researchers at the University of Edinburgh have developed a defined media and serum-free process for generating anterior definitive endoderm (ADE) cells from mouse embryonic stem cells. More
Researchers at the University of Edinburgh have synthesised a unique class of biodegradable, non-toxic cationic lipids that exhibit excellent transfection efficiencies in primary and stem cell lines, in addition to well known immortalised varieties More
Biomarkers that allow the rapid identification of an ectopic or extra-uterine pregnancy More
A monoclonal antibody that recognises a glycoprotein of unknown function on the surface of apoptotic neutrophils More
A monoclonal antibody that recognises a sub-population of neutrophils that are believed to be in the ‘late’ stages of apoptosis More
Deals
To view this information, you must subscribe to Partneringtools.
Press Releases
(21st Feb 2008) Researchers at the University of Edinburgh are developing a device that could be permanently implanted into the body and would be capable of delivering daily doses of a drug for up to one year. More
(6th Feb 2008) Scientists have generated human liver cells from embryonic stem cells that could be used to screen potentially harmful side-effects of drugs before they are trialled in patients. More
(25th Oct 2007) The University of Edinburgh has agreed a contract to market a technology which can clean surgical instruments contaminated by CJD, and save the health industry thousands of pounds. More
Head office
The University of Edinburgh
Edinburgh Research and Innovation
1 Roxburgh Street
Edinburgh
Lothian
EH8 9TA
United Kingdom
Tel: +44 131 650 9090
Fax: +44 131 650 9031
www | email
Edinburgh Research and Innovation
1 Roxburgh Street
Edinburgh
Lothian
EH8 9TA
United Kingdom
Tel: +44 131 650 9090
Fax: +44 131 650 9031
www | email
Contact details
Mr Alex Proudfoot
Marketing Manager
Edinburgh Research and Innovation
Marketing Manager
Edinburgh Research and Innovation
Dr Wendy Nicholson
Business Manager (Science & Engineer
Edinburgh Research and Innovation
Request more information
Business Manager (Science & Engineer
Edinburgh Research and Innovation
Request more information
Dr Giles Dudley
Business Development Executive
Medicine & Veterinary Medicine
Request more information
Business Development Executive
Medicine & Veterinary Medicine
Request more information
Company figures
Annual Turnover:
£477.1 million (2007)
Number of employees: 7691
Number of employees: 7691
Related categories
- Industry sector
- Animal health
- Biotech
- Diagnostic
- Drug delivery
- Medical device
- Pharmaceutical
- Animal health
- Animal health / Diagnostic
- Biotechnology
- Biotechnology / Assay systems
- Biotechnology / Diagnostic test systems
- Biotechnology / Other
- Biotechnology / Stem cells
- Biotechnology / Nanotechnology
- Diagnostic
- Diagnostic / Imaging
- Diagnostic / MRI
- Diagnostic / Supplies
- Diagnostic / Biomarker-based diagnostics
- Diagnostic / Antibody-based diagnostics
- Diagnostic / Supplies / Reagents
- Diagnostic / Supplies / Biological materials
- Drug discovery
- Drug discovery / Bioinformatics
- Drug discovery / Combinatorial biology
- Drug discovery / Combinatorial chemistry
- Drug discovery / Genomics
- Drug discovery / High throughput screening
- Drug discovery / Proteomics
- Drug discovery / Drug research platforms
- Technology transfer
- Universities
- Research tools
- Research tools / Antibodies
- Research tools / Cell lines
- Research tools / Mouse models
- Research tools / Reagents
- Research tools / Biomarkers
- Clinical research
- Consultancy
- Research
- Therapeutic target
- Accident and Trauma
- Accident and Trauma / Stroke/traumatic brain injury
- Allergy
- Cardiovascular
- Central Nervous System
- Genito-urinary
- Genito-urinary / Gender related medicine female
- Genito-urinary / Gender related medicine female / Pregnancy
- Hospital and Surgery
- Hospital and Surgery / Transplantation
- Immune related disorders
- Immune related disorders / Organ transplant rejection
- Immune related disorders / Transplant rejection
- Infectious diseases
- Infectious diseases / Diseases
- Infectious diseases / Diseases / Infection, viral (other)
- Infectious diseases / Diseases / Creutzfeldt-Jakob disease
- Infectious diseases / Diseases / Infectious disease (other)
- Musculoskeletal
- Oncology
- Respiratory
- Respiratory / Asthma
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us